Annabel Maruani
3
Documents
Identifiants chercheurs
- annabel-maruani
- ResearcherId : L-9017-2015
- IdRef : 088646270
- 0000-0003-3734-810X
- ResearcherId : http://www.researcherid.com/rid/L-9017-2015
Présentation
Publications
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 2
|
Efficacy and safety of methotrexate versus placebo as add-on therapy to H1 antihistamines for patients with difficult-to-treat chronic spontaneous urticaria: A randomized, controlled trialJournal of The American Academy of Dermatology, 2020, 82 (1), pp.240-243. ⟨10.1016/j.jaad.2019.07.097⟩
Article dans une revue
hal-02623128v1
|
|
A new phototherapy regimen during winter as an add-on therapy, coupled with oral vitamin D supplementation, for the long-term control of atopic dermatitis study protocol for a multicentre, randomized, crossover, pragmatic trial - the PRADA trialTrials, 2019, 20 (1), pp.184. ⟨10.1186/s13063-019-3276-9⟩
Article dans une revue
hal-02086876v1
|
Evaluation of a low-dose methotrexate added to h1-antihistamines regimen for severe chronic spontaneous urticaria: a phase III, randomized, placebo-controlled trial24. World Congress of dermatology (WCD 2019), Jun 2019, Milan, Italy
Communication dans un congrès
hal-02736447v1
|